Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pyure's patented hydroxyl generation technology has demonstrated the ability to reduce airborne and surface bacteria, mold, viral pathogens, VOCs and odors by up to 98% in real-world environments. Their products are designed for continuous operation around people and animals without material degradation or safety concerns[3].
Clinical or field studies referenced include efficacy data from independent researchers such as Kishor Khankari Ph.D., Fellow ASHRAE[3].
Products are used globally across commercial & industrial settings for infection prevention.
No drug development pipeline—products are devices/technologies.
Not a therapeutics company but relevant to healthcare/life sciences due to infection control focus.
Pipeline breadth/pipeline/programs not applicable as it does not develop drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pyure.